Profound Medical Corp T.PRN

Alternate Symbol(s): PROF

Healthcare Medical Devices

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low -, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

TSX:PRN - Post by User

Profound Medical Corp

Bullboard Posts

Post by VerusSemperSorson Apr 03, 2018 2:43pm

100 Views

Post# 27822790

Koninklijke Philips N.V holds over 10% of float -bought 7.4M

shares at the end of July 2017.

We probably know them best for consumer electronics, shavers, lighting, etc. The are big into healthcare now.

I expect that they knew what they were doing when they acquired 7.4 million shares at $1.10 per share on July 31, 2017. Maybe they'll be acquiring more?

Bullboard Posts

Cameco raises uranium output as Q3 results surge